Skip to content
Disclosery

ORBIMED ADVISORS LLC: EWTX position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on EWTX, newest first. How the timeline and the estimate are built.

ORBIMED ADVISORS LLC held 15,518,492 EWTX shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 15,518,492 shares
    Change vs previous 13F 0 shares

    11.94% of the 13F portfolio, value $630,516,330.

    13F-HR 0001172661-26-003740 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 15,518,492 shares
    Change vs previous 13F 0 shares

    10.66% of the 13F portfolio, value $488,832,498.

    13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 15,518,492 shares
    Change vs previous 13F 0 shares

    7.88% of the 13F portfolio, value $385,091,379.

    13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 15,518,492 shares
    Change vs previous 13F 0 shares

    6.04% of the 13F portfolio, value $251,709,940.

    13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 15,518,492 shares
    Change vs previous 13F +496,771 shares

    5.12% of the 13F portfolio, value $203,447,430.

    13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 15,021,721 shares
    Change vs previous 13F 0 shares

    7.94% of the 13F portfolio, value $330,477,862.

    13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 15,021,721 shares
    Change vs previous 13F 0 shares

    8.33% of the 13F portfolio, value $401,079,951.

    13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 15,021,721 shares
    Change vs previous 13F not available

    7.34% of the 13F portfolio, value $400,929,733.

    13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).